This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
Freelance translator and/or interpreter, Verified site user
Data security
This person has a SecurePRO™ card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePRO™ card you must be a ProZ.com Business member or Plus subscriber.
Affiliations
This person is not affiliated with any business or Blue Board record at ProZ.com.
Services
Translation, Editing/proofreading
Expertise
Specializes in:
Medical: Pharmaceuticals
Medical (general)
Medical: Health Care
Food & Drink
Medical: Dentistry
Education / Pedagogy
Marketing / Market Research
Real Estate
Management
Biology (-tech,-chem,micro-)
Also works in:
Tourism & Travel
Other
Environment & Ecology
Certificates, Diplomas, Licenses, CVs
Botany
Zoology
Law: Patents, Trademarks, Copyright
Law: Contract(s)
Law (general)
Advertising / Public Relations
Business/Commerce (general)
Finance (general)
Cooking / Culinary
Human Resources
Insurance
Media / Multimedia
Sports / Fitness / Recreation
Social Science, Sociology, Ethics, etc.
Transport / Transportation / Shipping
Patents
Science (general)
Linguistics
Psychology
Economics
History
Cosmetics, Beauty
Medical: Instruments
Livestock / Animal Husbandry
More
Less
Rates
English to Russian - Rates: 0.06 - 0.08 EUR per word / 12 - 20 EUR per hour German to Russian - Rates: 0.06 - 0.08 EUR per word / 12 - 20 EUR per hour Russian to English - Rates: 0.06 - 0.08 EUR per word / 12 - 20 EUR per hour
English to Russian: Inactivated Poliomyelitis Vaccine, General field: Medical Detailed field: Medical: Pharmaceuticals
Source text - English The study was an open, randomised, controlled, prospective, phase II study in children four years of age with blinded serological evaluation. The immunogenicity and safety of IPV-Vero administered as a combination booster vaccine was evaluated and compared with the regular IPV-MK. Additionally, the immunogenicity and safety of three different acellular pertussis vaccines were compared with whole-cell pertussis vaccine in combination vaccines with diphtheria toxoid, tetanus toxoid and inactivated poliomyelitis vaccine. All children were previously immunised with four doses of DPT-IPV at the age of 3, 4, 5
and 11 months. A total of 180 children completed the study.
Translation - Russian Данное исследование являлось открытым, рандомизированным, контролируемым проспективным исследованием II фазы, исследование проводилось с участием детей в возрасте четырех лет, серологические исследования проводились с использованием слепого метода. Иммуногенность и безопасность вакцины IPV-Vero, применявшейся в качестве комбинированной бустерной (ревакцинирующей ) дозы, оценивалась и сравнивалась с обычной IPV-MK вакциной. Также было проведено сравнение иммуногенности и безопасности трех различных ацеллюлярных вакцин против коклюша и цельноклеточных вакцин против коклюша в комбинированных вакцинах, содержащих дифтерийный анатоксин, столбнячный анатоксин и инактивированную вакцину против полиомиелита. Всем детям ранее были сделаны прививки с использованием четырех доз DPT-IPV вакцины в возрасте 3, 4, 5 и 11 месяцев. Всего 180 детей завершили участие в исследовании.
English to Russian: Fenspiride General field: Medical Detailed field: Medical: Pharmaceuticals
Source text - English Fenspiride inhibits products of certain mediators secreted by respiratory tract cells particularly the release of TNF alpha and reduces migration of inflammation cells through the diminished formation of chemotaxis factors. Oral administration of fenspiride at doses of 60 to 200 mg/kg of body weight was shown to inhibit the endotoxin-induced migration of neutrophils into peritoneal cavities, as well as exudation into peritoneal cavities (Mihaltan 2003). The effects of fenspiride lead to changes to the activity of the protein MLP (Met-Leu- Phe) in pulmonary alveolar macrophages via phosphokinase C (PKC). The restriction of TNF activity in neutrophils by fenspiride, along with the influence on reduction of the cAMP and
cGMP concentration in the bronchial tree, confirm the potential for fenspiride to control the inflammatory process, including an anti-exudative action, and via suppression of chemotaxis and release of cytokines, to limit the formation of cellular infiltrate (Plusa and Ochwat 2005).
Translation - Russian Фенспирид ингибирует производные некоторых медиаторов, вырабатываемые клетками дыхательных путей, в частности, фактор некроза опухолей (ФНО) альфа, а также снижает способность воспалительных клеток к передвижению (миграции), и уменьшает образование факторов хемотаксиса. Доказано, что пероральный прием фенспирида в дозировке от 60 до 200 мг/кг массы тела, подавляет вызванную эндотоксинами миграцию нейтрофилов в брюшную полость, а также экссудацию в брюшную полость (Mihaltan 2003). Воздействие фенспирида приводит к изменению активности белка MLP (Met-Leu-Phe) в альвеолярных макрофагах легких посредством фосфокиназы С (ФКС). Снижение активности ФНО в нейтрофилах, вызванное фенспиридом, а также снижение концентрации циклического аденозинмонофосфата (cAMP) и циклического гуанозин-монофосфата в бронхиальном дереве, подтверждает, что фенспирид обладает способностью контролировать воспалительный процесс, включая антиэкссудативное действие; а подавляя хемотаксис и выработку цитокинов, препарат способен снижать образование клеточного инфильтрата (Plusa и Ochwat 2005).
Russian to English: Decitabin General field: Medical
Source text - Russian Длительность наблюдения пациентов, получавших
децитабин, составила от 80 до 120 дней. ПР достигнута у 6 пациентов: у 1 — после 1 курса децитабина, у 4 — после 4 курсов (у одного из них после 2 курсов достигнута КР) и у 1 пациента — после 8 курсов (после 3 курсов у него достиг- нута КР). У 3 пациентов из 6 имелся диагноз РАИБ-2, у других 3 — один из следующих диагнозов: РАИБ-1, РА- ИБ-2 с трансформацией в OMJ1 и рецидив OMJ1, развившийся из МДС. В дальнейшем у 4 из 6 больных заболевание прогрессировало: после 6,8, 8,6 курсов через 7,6,12,4,12,7 и 29 мес от начала лечения соответственно. У 2 больных сохраняется ПР: у одного продолжительностью 14 мес, у другого — 17 мес. Медиана продолжительности ремиссии у больных составила 12,8 мес (от 2,7 до 24 мес). Лечение прервано у 5 пациентов (у 1 после первого курса, у 4 после 2 курсов): у 2 развились тяжелые инфекционные осложнения, еще у 2 наблюдалось прогрессирование заболевания в ОМЛ, одна больная скончалась от
инфекционных осложнений. Резистентность к проводи-
мой терапии констатирована у 2 больных: у одного после 3 курсов, у другого после 4.
Translation - English The patients receiving decitabin were observed for 80 – 120 days. Complete remission (CR) was achieved in 6 patients: in 1 – after 1 course of decitabin, in 4 – after 4 courses (in one of them after 2 courses partial remission (PR) was achieved) and in 1 patient – after 8 courses (after 3 courses PR was achieved). Three patients out of 6 were diagnosed with RAEB-2 (refractory anemia with excess blasts), the rest 3 patients were diagnosed with one of the following: RAEB-1, RAEB-2 with transformation into AML (Acute myeloid leukemia) and relapse of AML, developed from myelodysplastic syndrome (MDS). Later on in 4 patients the disease progressed after 6, 8, 8, 6 courses, 7.6, 12.4, 12.7 and 29 months after the therapy initiation, respectively. In 2 patients CR remained: in one patient it lasted for 14 months, in the other – for 17 months. Median duration of remission was 12.8 month (2.7 to 24 months). The treatment was discontinued in 5 patients (in one after the first course, in 4 after 2 courses): 2 patients developed severe infectious complications, in 2 patients the disease progressed into AML, one female patient died because of infectious complications.
English to Russian: Zinc General field: Medical
Source text - English Bioavailability
Interactions with a number of dietary factors influence zinc uptake. Ligands, such as phytate, form insoluble complexes with zinc and prevent absorption. Calcium increases binding of zinc by phytate
(Oberleas et al, 1966). Larger doses of calcium can decrease net zinc absorption (Spencer et al, 1984; Wood and Zheng, 1995). High iron content in the diet decreases zinc absorption. Earlier reports
indicated that folic acid can also inhibit zinc retention and metabolism (Milne, 1989; Milne et al, 1984; Milne et al, 1990), but more recent evidence indicates that folic acid does not adversely affect zinc status (Kauwell et al, 1995). Copper and zinc compete for absorption but it appears unlikely that modestly increased intakes of copper interfere with zinc absorption. Histidine, methionine and cysteine are thought to facilitate zinc absorption (these amino acids remove zinc from the zinc-calcium-phytate
complexes) (Mills, 1985).
Translation - Russian Биодоступность
На усвоение цинка влияет ряд пищевых факторов. Так лиганды, такие как соль фитиновой кислоты, образовывают с цинком нерастворимые комплексы, что препятствует всасыванию цинка. Кальций усиливает способность солей фитиновой кислоты связываться с цинком (Oberleas в соавт., 1966). Большие дозы кальция могут снизить общее всасывание цинка (Spencer в соавт., 1984; Wood и Zheng, 1995). Высокое содержание железа в пище снижает всасывание цинка. Ранее сообщалось, что фолиевая кислота также может подавлять удерживание цинка в организме и его метаболизм (Milne, 1989; Milne в соавт., 1984; Milne в соавт., 1990), однако, согласно последним данным, фолиевая кислота не оказывает влияния на цинк (Kauwell в соавт., 1995). Медь и цинк конкурируют за всасывание, однако, маловероятно, что немного повышенное потребление меди повлияет на всасывание цинка. Гистидин, метионин и цистеин могут повышать всасывание цинка (эти амино кислоты способны отщеплять цинк от комплекса цинк-кальций-фитиновая кислота) (Mills, 1985).
More
Less
Translation education
Master's degree - Kazan State Pedagogical University (Russia)
Experience
Years of experience: 18. Registered at ProZ.com: Oct 2014.
English to Russian (Kazan State Pedagogical University, verified) English to Russian (State National University of Science and Technolog, verified) Russian to English (State National University of Science and Technolog, verified) German to Russian (Kazan State Pedagogical University, verified) Russian to English (Kazan State Pedagogical University)
Memberships
N/A
Software
Adobe Acrobat, Adobe Photoshop, MemSource Cloud, MetaTexis, Microsoft Excel, Microsoft Word, Powerpoint
Bio
EDUCATION:
Kazan State Pedagogical University, Foreign Languages Department, Diploma with honors – Teacher of English and German languages
Moscow State University for Humanities named after M.A. Sholokhov, Diploma with honors – Speech Therapist. (is considered as a medical education, allowing to work in hospitals with stroke patients)
National University of Science and Technology MISIS «former Moscow State Institute of Steel and Alloys”
Diploma of further additional to higher education – Translator in the sphere of business communications”
WORKING EXPERIENCE:
2006-2009 Translator in LLC “Yar Reliability and Relations”, Moscow (“Yar Reliability and Relations” was a partner company of American adoption agency World Child International. I translated the dossiers of american families,desiring to adopt a child, medical histories of adopted children and judicial documents, I also accompanied the families to hotels, notary, orphan homes and hospitals)
2009-2014 Freelance translator in Russia
Since 2016 - Freelance translator in Germany
Working as freelancer, I translated a great variety of medical and pharmaceutical documents. While working with translation agencies, I translated medical and pharmaceutical documents of the following companies: Bayer AG, Novartis, Merck KGaA, Sandoz, Gedeon Richter, Abbott Laboratories, Pfizer, Sanofi-Aventis and others.
I am experienced in translating of clinical trials, clinical researches, clinical studies, pre-clinical studies, bioequivalence studies, clinical study reports (CSR), clinical study protocols (CSP), clinical overviews, investigator’s brochures, summaries of product characteristics (SmPC), patient information leaflets (PILs), periodic safety update reports (PSUR), toxicity studies, acute toxicity studies, sub-chronic toxicity studies, chronic toxicity studies, new drug applications (NDA), evaluation of safety and efficacy, synopses of individual studies, reference safety information (RSI), Individual Case Safety Reports (ICSR), spontaneous reports, user manuals for medical devices, articles from medical journals, documents for the Ministry of Healthcare and others.
I also translated other types of documents, e.g. business agreements, financial reports, technical manuals, advertising brochures, articles about art, music, sport, attractions, education and others.
PERSONAL QUALITIES
Attention to details, willing and ability to learn and search information, ability to handle pressure and meet deadlines. I love my job.
Please feel free to contact me if you need any further information.
This user has earned KudoZ points by helping other translators with PRO-level terms. Click point total(s) to see term translations provided.
Keywords: Medical translation, pharmaceutical translation, health care, cardiology, clinical trials, clinical research, clinical studies, pre-clinical studies, bioequivalence studies, clinical study report (CSR). See more.Medical translation, pharmaceutical translation, health care, cardiology, clinical trials, clinical research, clinical studies, pre-clinical studies, bioequivalence studies, clinical study report (CSR), clinical study protocol (CSP), clinical overview, investigator’s brochure, medicinal product, summary of product characteristics (SmPC), patient information leaflets (PILs), periodic safety update report (PSUR), toxicity studies, acute toxicity studies, sub-chronic toxicity studies, chronic toxicity studies, new drug application (NDA), evaluation of safety and efficacy, synopses of individual studies, reference safety information (RSI), Individual Case Safety Report (ICSR), spontaneous reports, literature reports, solicited reports, medically confirmed serious listed cases, medically confirmed serious unlisted cases, medically unconfirmed cases
pharmacodynamics, pharmacokinetics, pharmacodynamic properties, pharmacokinetic properties, absorption, distribution, metabolism, elimination, pharmacokinetic drug interactions, overdose, adverse events, adverse effects, adverse drug reactions, undesirable effects, contraindications, preclinical safety data, nature and contents of container
common technical document summary, uniformity of dosage units, content uniformity, impurities and degradation products, dissolution, disintegration, microbial contamination, assay of active substance by HPLC, validation of analytical procedures, batch analyses, characterization of impurities, justification of specifications, identification of active substance, container closure system, stability studies, infections and infestations, neoplasms benign, malignant and unspecified, blood and lymphatic system disorders, immune system disorders, endocrine disorders, metabolism and nutrition disorders, psychiatric disorders, nervous system disorders, eye disorders, ear and labyrinth disorders, cardiac disorders, vascular disorders, respiratory, thoracic and mediastinal disorders, gastrointestinal disorder, hepatobiliary disorder, skin and subcutaneous tissue disorder, musculoskeletal and connective tissue disorders, renal and urinary disorders, pregnancy, puerperium and perinatal conditions, reproductive system and breast disorders, congenital, familial and genetic disorders, general disorders and administration site conditions, investigations, injury, poisoning and procedural complications, surgical and medical procedures, social circumstances. See less.
This profile has received 45 visits in the last month, from a total of 8 visitors
Expertise 
Portfolio 